Overview

Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether disinvestment in hydroxyl-ethyl starches (HES) for patients undergoing cardiac surgery was safe and effective.
Details
Lead Sponsor:
Lawson Health Research Institute
Collaborator:
Western University, Canada
Treatments:
Hydroxyethyl Starch Derivatives